Abstract
The effect of the 5-HT3 receptor antagonist, ondansetron, on the decrease in hunger produced by amphetamine was assessed in nine male volunteers using a double-blind cross-over design. Amphetamine (15 mg orally) produced a significant decrease in self-ratings of hunger 2.5 h after administration. This effect was significantly attenuated by pre-treatment with ondansetron (12 mg orally over 24 h). These findings in humans are consistent with data from animal studies suggesting that ondansetron can attenuate certain catecholamins-mediated behaviours produced by amphetamine. However, explanations founded on pharmacokinetic factors cannot be presently excluded.
This is a preview of subscription content, log in via an institution to check access.
References
Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ (1990) Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat. Neuropharmacology 29:1037–1045
Blundell J (1985) Psychopharmacology of centrally acting anorectic agents. In: Sandler M, Silverstone T (eds) Psychopharmacology and food. Oxford University Press, Oxford New York Tokyo, pp 71–109
Carboni E, Acquas E, Frau R, DiChiara G (1989) Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164:515–519
Cooper SJ (1991) Ingestional responses following benzodiazepine receptor ligands, selective 5-HT1A agonists and selective 5-HT3 receptor antagonists. In: Rogers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. John Wiley, Chichester New York Brisbane Toronto Singapore, pp 233–265
Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92:881–894
Costall B, Naylor RJ, Tyers MB (1990) The psychopharmacology of 5-HT3 receptors. Pharmacol Ther 47:181–202
Hoebel BG, Hernandez L, Schwartz DH, Mark GP, Hunter GA (1989) Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behaviour. Ann NY Acad Sci 575:171–191
Robertson DRC, Renwick AG, Wood ND, Cross N, Macklin BS, Fleming JS, Waller DG, George CF (1990) The influence of levodopa on gastric emptying in man. Br J Clin Pharmacol 29:47–53
Samanin R, Bendotti C, Bernasconi S, Borroni E, Garattini S (1977) Role of brain monoamines in the anorectic activity of mazindol andd-amphetamine in the rat. Eur J Pharmacol 43:117–124
Silverstone T, Fincham J, Wells B, Kryiakides M (1980) The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine sulphate on hunger, arousal and mood in human volunteers. Neuropharmacology 19:1235–1237
Spiegel R (1989) Psychopharmacology: an introduction, 2nd edn. John Wiley, Chichester New York Brisbane Toronto Singapore, pp 69–71
Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, McCarty RL, Ciociola A (1990) GR 38032F (ondansetron), a selective 5-HT3 receptor antagonist, slows colonic transit in healthy man. Digest Dis Sci 35:477–480
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silverstone, P.H., Johnson, B. & Cowen, P.J. Does ondansetron attenuate amphetamine-induced behaviour in human volunteers?. Psychopharmacology 107, 140–141 (1992). https://doi.org/10.1007/BF02244979
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244979